[1]Lange,UdoE.W.;Baucke,Dorit;Hornberger,Wilfried;Mack,Helmut;Seitz,Werner;Hoeffken,H.Wolfgang[BioorganicandMedicinalChemistryLetters,2003,vol.13,#12,p.2029-2033]
[2]CurrentPatentAssignee:ABBVIEINC-US6740647,2004,B1Locationinpatent:Pagecolumn48
52160-51-7
869941-56-0
99042-96-3
2584-48-7 | N-Methyl-3-oxo-n-phenylbutanamide | AA00BVEM | MFCD00129141
330581-20-9 | Disodium 1-naphthol-3,6-disulfonate hydrate | AA00BX8W | MFCD00003966
38603-09-7 | 2,6-Dibromoanisole | AA00BXE7 | MFCD00093270
37441-50-2 | 1,4-Butanesultam | AA00BXL0 | MFCD04038916
38081-60-6 | Phenyl(piperidin-4-yl)methanol | AA00BXRI | MFCD05864581
40990-52-1 | 4-Hydroxy-6-indolecarboxylic acid | AA00BXXB | MFCD04973988
345909-25-3 | THIOGUANOSINE HYDRATE | AA00BY6O | MFCD00149353
39643-31-7 | 2-Piperidinoaniline | AA00BYBY | MFCD00047467
348086-68-0 | 2-Methylamino-4-methylthiazole-5-sulfonamide | AA00BYGN | MFCD06658471
388088-79-7 | [5-(2-METHYL-1,3-THIAZOL-4-YL)-3-ISOXAZOLYL]METHANOL | AA00BYM2 | MFCD03086111